BIOX
BIOX
NASDAQ · Chemicals

Bioceres Crop Solutions Corp

$0.41
+0.02 (+4.09%)
As of Mar 30, 10:11 PM ET ·
Financial Highlights (FY 2026)
Revenue
337.06M
Net Income
-56,037,637
Gross Margin
39.0%
Profit Margin
-16.6%
Rev Growth
+0.5%
D/E Ratio
1.04
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 39.0% 39.0% 35.4% 35.4%
Operating Margin -0.7% -0.6% 15.8% 13.1%
Profit Margin -16.6% -15.8% 12.8% 14.0%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 337.06M 335.41M 10.13M 10.46M
Gross Profit 131.38M 130.74M 3.59M 3.71M
Operating Income -2,258,282 -2,022,543 1.61M 1.37M
Net Income -56,037,637 -50,187,952 1.30M 1.47M
Gross Margin 39.0% 39.0% 35.4% 35.4%
Operating Margin -0.7% -0.6% 15.8% 13.1%
Profit Margin -16.6% -15.8% 12.8% 14.0%
Rev Growth +0.5% +0.5% +24.0% +22.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 6.80M 6.80M 7.53M 9.76M
Total Equity 6.53M 6.53M 24.77M 27.77M
D/E Ratio 1.04 1.04 0.30 0.35
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -9,680,623 -9,151,748 2.20M 2.21M
Free Cash Flow 1.19M 1.17M